ºÚÁϳԹÏÍø

Discovery led by Institute for Glial Sciences at ºÚÁϳԹÏÍø suggests new path to regenerative therapies for MS

Earlier this month, ºÚÁϳԹÏÍø School of Medicine’s Rania Ziar, a PhD student, and advisor Paul Tesar, professor in the Department of Genetics and Genome Sciences, were named to the HHMI Gilliam Fellows Program 2025 cohort. This program—which supports graduate students and the...

ºÚÁϳԹÏÍø researchers reveal cell development role for two ‘epigenetic’ markers, opening door for new treatment for leukemia

A team of researchers from ºÚÁϳԹÏÍø School of Medicine’s Department of Pharmacology recently conducted a study to better understand how essential transport proteins function in Mycobacterium smegmatis, a model organism used to study tuberculosis-related bacteria. Their find...

Innovative research paves way for more effective treatment for ALS and other neurodegenerative diseases

ºÚÁϳԹÏÍø’s close proximity to world-class healthcare facilities is a draw for many students considering careers in medical settings. That was true of Rae Dwyer, who arrived on campus as an undergraduate student in August 2019. Now a second-year student in the Master of Scien...

The Case Comprehensive Cancer Center (Case CCC), designated a comprehensive consortium cancer center by the National Cancer Institute (NCI) of the National Institutes of Health, has received a $25.5 million Cancer Center Support Grant from NCI. The renewal marks 38 years of continuous NCI funding, d...

Vaccines have a history that stretches back over 1,000 years, with major scientific breakthroughs emerging in the 1800s and continuing to shape public health today. Members of the ºÚÁϳԹÏÍø community are invited to join Siegal Lifelong Learning Program for its upcoming “Vaccin...

Up to 70% of children with autism spectrum disorder (ASD) experience chronic digestive issues—and ºÚÁϳԹÏÍø School of Medicine’s Marissa Scavuzzo wants to not only understand why, but to determine how to treat it. Her latest research into the gut’s role in children with ASD has...

CLEVELAND—Amyotrophic lateral sclerosis (ALS), known as Lou Gehrig’s disease, is an incurable neurological disorder affecting motor neurons—nerve cells in the brain and spinal cord that control voluntary muscle movement and breathing. Many ALS clinical trials, including those testing promising drug...